Bridging the Gap Between Inpatient and Outpatient Care: A Shift in European Healthcare Policies

By Staff Writer

August 4, 2023

The healthcare landscape in Europe is undergoing a significant transformation. Several nations have identified a gap between inpatient and outpatient care as a potential barrier to ensuring equitable and affordable access to medicines.

With an aim to bridge this gap, countries are optimising reimbursement and procurement policies for a more integrated and coordinated approach. However, there is a dearth of evidence on the impact of these policies at the interface of inpatient and outpatient sectors on access to medicines.

Over time, policy-makers have increasingly shifted their focus towards medicines used in hospitals. They have introduced policies in the inpatient sector that were previously only used in the outpatient sector, including tools to support evidence-based decision-making (e.g., Health Technology Assessment – HTA). This shift can be seen as a response to developments in the pharmaceutical sector.

With the advent of highly specialised medicines with high price tags for small patient populations that are mainly used in the hospital setting, such as gene therapies, it is crucial to scale up capacity and policy action in the hospital sector.

While these policies aim to ensure affordability and financial sustainability of high-priced medicines in hospitals, another motivation is to address the impact of hospital prescribing of medication initiated during a patient’s hospital stay on outpatient use.

The treatment of chronic diseases often requires continuous medication for years. Increased use of therapeutically equivalent but less expensive alternatives, such as generic and biosimilar medicines, would ease the burden on public budgets without compromising quality of care, thus enhancing patient access.

These challenges can be addressed through appropriate demand-side measures, such as generic substitution or prescribing by the International Non-Proprietary Name (INN) in the outpatient sector.

However, the road to bridging the inpatient-outpatient gap is not without challenges. It requires institutional and organisational changes, and the establishment of new institutions and committees, with representation from both sectors.

Despite the importance of the topic, it is still a relatively new research area lacking an accepted terminology and taxonomy. Yet, the shift in focus towards bridging the inpatient-outpatient gap is a promising development in the European healthcare landscape.

Reference url

Recent Posts

Collaboration Cardiac Surgery: Boosting Surgical Volumes Through Multidisciplinary Teams

By João L. Carapinha

September 1, 2025

Cardiovascular Business recently examines how closer collaboration cardiac surgery between interventional cardiologists and cardiac surgeons can increase patient referrals for surgical interventions. This is especially important as less-invasive procedures like transcatheter interventions grow in...
Mounjaro Price Increase UK: Impacts on Access and Health Economics
Eli Lilly is raising Mounjaro's UK price by 170% on September 1, 2025. The highest dose will jump from £122 to £330 monthly. But the company has negotiated discounts with pharmacies. This will lower the effective price to £247.50. This hike aims to align international pricing as it responds to pr...
Innovative Strategies of MoonLake Immunotherapeutics HS in Targeting Inflammatory Diseases

By João L. Carapinha

August 30, 2025

MoonLake Immunotherapeutics HS, under the leadership of CEO Jorge Santos da Silva, is reimagining traditional biotech strategies with a concentrated approach to immunotherapeutic drug development. Utilizing innovative nanobody technology, the company is making strides in treating inflammatory dis...